Countries classified as middle-income by the World Bank face significant challenges in financing their healthcare systems, despite surpassing thresholds that typically reduce their eligibility for international aid. This transition, often celebrated as a sign of economic progress, has increasingly revealed a paradox whereby many middle-income nations are caught in a "health trap," unable to fully fund their healthcare needs while losing access to concessional support.

The World Bank classifies countries based on gross national income per capita, and crossing from low- to middle-income status usually results in a phase-out of grants and concessional loans from global health programs. However, this shift does not always align with the countries’ actual capacity to cover growing health expenditures. Disease burdens, including tuberculosis, HIV, and non-communicable diseases, remain high in many middle-income states, which now account for over 70 percent of the global poor and a substantial share of disease-related mortality.

Many middle-income countries struggle with limited fiscal space due to underdeveloped tax systems, often collecting less than 15 percent of GDP in revenue, partly because of large informal economies. In addition, rising debt-service costs further constrain public spending on health. As external funding transitions to commercial borrowing, interest payments consume increasing portions of national budgets, leaving fewer resources available for essential health services.

The experience of Romania highlights the consequences of this transition. After joining the European Union in 2007, Romania’s economy grew, leading to the withdrawal of Global Fund support for HIV prevention in 2010. The government failed to fill the funding void, causing harm-reduction programs to collapse and a resurgence of infections among vulnerable populations.

The expectation that middle-income countries will replace declining aid with market-based financing and private sector investment often falls short of reality. While private capital may enter healthcare sectors, it typically targets profit-generating areas such as urban hospitals and specialist care, leaving critical public health functions underfunded. This dynamic risks entrenching two-tier health systems that deepen inequalities and hinder progress toward universal health coverage.

Experts warn that without comprehensive tax reforms, stronger fiscal capacity, and sustained international support tailored to the realities of middle-income countries, many nations will remain trapped in a difficult position: too affluent to qualify for aid, yet too financially strained to fully meet their health priorities. This gap poses significant challenges not only for individual countries but also for global health objectives aimed at controlling infectious diseases and managing chronic conditions worldwide.